Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Nosocomial bloodstream infections are important causes of morbidity and mortality. In this study, concurrent surveillance for nosocomial bloodstream infections at 49 hospitals over a 3-year period detected >10,000 infections. Gram-positive organisms accounted for 64% of cases, gram-negative organisms accounted for 27%, and 8% were caused by fungi. The most common organisms were coagulase-negative staphylococci (32%), Staphylococcus aureus (16%), and enterococci (11%). Enterobacter, Serratia, coagulase-negative staphylococci, and Candida were more likely to cause infections in patients in critical care units. In patients with neutropenia, viridans streptococci were significantly more common. Coagulase-negative staphylococci were the most common pathogens on all clinical services except obstetrics, where Escherichia coli was most common. Methicillin resistance was detected in 29% of S. aureus isolates and 80% of coagulase-negative staphylococci. Vancomycin resistance in enterococci was species-dependent--3% of Enterococcus faecalis strains and 50% of Enterococcus faecium isolates displayed resistance. These data may allow clinicians to better target empirical therapy for hospital-acquired cases of bacteremia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Candida species are the fourth most common cause of hospital-acquired bloodstream infections (BSI) in the United States (5, 9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
In the citing paper
“These species proportions are very similar to those previously reported from the northeastern United States (9).”
In the citing paper
“The National Epidemiology of Mycoses Survey study demonstrated geographic variations in species distributions throughout the United States, with C. albicans ranging from 46% in the northeast to 70% in the southwest and C. glabrata ranging from 15% in the southwest to 26% in the northeast (9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984 · cited 3×
“Nonetheless, prospective surveillance projects such as ours will allow rapid detection of such infections, which initially appeared in Japan [17, 18] and have been reported in the United States [19].”
BackgroundHiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00192-2 · Cited by 424 · cited 1×
“Several subprojects have evaluated samples of organisms from this study and have included validation measures, such as reidentification of species and retesting of antimicrobial susceptibilities in the Special Microbiology Laboratory at the University of Iowa College of Medicine [6–14].”
BackgroundSelf-citationPfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00240-x · Cited by 331
Self-citationCeftazidime Resistance Among Selected Nosocomial Gram-Negative Bacilli In The United States
Burwen, D. R., Banerjee, S. N., Gaynes, R. P., & System, T. N. N. I. S. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.6.1622 · Cited by 214
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
Ena, J. (1993) · JAMA · doi:10.1001/jama.269.5.598 · Cited by 203
Jones, R. N., Marshall, S. A., Pfaller, M. A., Wilke, W. W., Hollis, R. J., Erwin, M. E., Edmond, M. B., & Wenzel, R. P. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00115-6 · Cited by 153
Self-citationMarshall, S. A., Wilke, W. W., Pfaller, M. A., & Jones, R. N. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00212-5 · Cited by 146
Self-citationAntimicrobial Resistance: Issues and Options
(1998) · National Academies Press eBooks · doi:10.17226/6121 · Cited by 129
Cited by
Items 401–500 of 1,001
Kontoyiannis, D. P., & Lewis, R. E. (2003) · Drug Resistance Updates · doi:10.1016/j.drup.2003.08.003 · Cited by 67
Wenzel, R. P., Sahm, D. F., Thornsberry, C., Draghi, D. C., Jones, M. E., & Karlowsky, J. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3089-3098.2003 · Cited by 67
Self-citationβ -Lactamases: which ones are clinically important?
Rice, L. B., & Bonomo, R. A. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0144 · Cited by 67
Harris, M., Mora-Montes, H. M., Gow, N. A. R., & Coote, P. J. (2009) · Microbiology · doi:10.1099/mic.0.026120-0 · Cited by 66
Lakshmaiah, K. C., Malabagi, A. S., Shetty, R., Sinha, M., Jayashree, R. S., & Govindbabu (2015) · Journal of Laboratory Physicians · doi:10.4103/0974-2727.163126 · Cited by 66
RAAD, I. I., Hachem, R. Y., Hanna, H. A., Fang, X., Jiang, Y., Dvorak, T. L., Sherertz, R. J., & Kontoyiannis, D. P. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.06.020 · Cited by 66
The human commensal yeast, Candida albicans, has an ancient origin
Lott, T. J., Fundyga, R. E., Kuykendall, R. J., & Arnold, J. (2005) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2005.01.012 · Cited by 66
Differential secretion of Sap4–6 proteins in Candida albicans during hyphae formation
Chen, Y.-C., Wu, C.-C., Chung, W.-L., & Lee, F.-J. S. (2002) · Microbiology · doi:10.1099/00221287-148-11-3743 · Cited by 58
Candidemia em hospital terciário do nordeste do Brasil
Hinrichsen, S. L., Falcão, É., Vilella, T. D. A. S., Colombo, A. L., Nucci, M., Moura, L. C. R. V., Rêgo, L. C., Lira, C., & Almeida, L. (2008) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822008000400014 · Cited by 65
Wisplinghoff, H., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01318.x · Cited by 65
Self-citationMixed Fungemia: Incidence, Risk Factors, and Mortality in a General Hospital
Jensen, J., Munoz, P., Guinea, J., Rodríguez‐Créixems, M., Peláez, T., & Bouza, E. (2007) · Clinical Infectious Diseases · doi:10.1086/518175 · Cited by 65
Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans
Lee, R. E. B., Liu, T. T., Barker, K. S., Lee, R. E., & Rogers, P. D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki105 · Cited by 58
Candidaemia in a London teaching hospital: analysis of 128 cases over a 7‐year period
Schelenz, S., & Gransden, W. R. (2003) · Mycoses · doi:10.1046/j.0933-7407.2003.00907.x · Cited by 56
The pathogenicity and virulence of the opportunistic pathogen Staphylococcus epidermidis
Burke, Ó., Zeden, M. S., & O’Gara, J. P. (2024) · Virulence · doi:10.1080/21505594.2024.2359483 · Cited by 64
Sennhenn‐Kirchner, S., Freund, F., Grundmann, S., Martin, A., Zepelin, M. B., Christiansen, H., Wolff, H. A., & Jacobs, H. (2008) · Clinical Oral Investigations · doi:10.1007/s00784-008-0229-1 · Cited by 64
Invasive Aspergillosis in Patients with Hematologic Malignancies
Wiederhold, N. P., Lewis, R. E., & Kontoyiannis, D. P. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.15.1592.31965 · Cited by 59
mecA - blaZ Corepressors in Clinical Staphylococcus aureus Isolates
Rosato, A. E., Kreiswirth, B. N., Craig, W. A., Eisner, W., Climo, M. W., & Archer, G. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1460-1463.2003 · Cited by 63
Invasive Fungal Infections in the ICU
Shoham, S., & Marwaha, S. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609355262 · Cited by 63
Clancy, C. J., Nguyen, M.-L., Cheng, S., Huang, H., Fan, G., Jaber, R. A., Wingard, J. R., Cline, C., & Nguyen, M. H. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.02018-07 · Cited by 62
Wengenack, N. L., & Binnicker, M. J. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.02.014 · Cited by 62
Aittakorpi, A., Kuusela, P., Koukila-Kähkölä, P., Vaara, M., Petrou, M. A., Gant, V. A., & Mäki, M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01461-12 · Cited by 62
Pathogenesis of Septic Shock: Implications for Prevention and Treatment
Calandra, T. (2001) · Journal of Chemotherapy · doi:10.1179/joc.2001.13.supplement-2.173 · Cited by 62
Cornely, O. A., B�hme, A., Buchheidt, D., Glasmacher, A. G., Kahl, C., Karthaus, M., Kern, W. V., Kr�ger, W., Maschmeyer, G., Ritter, J., et al. (2003) · Annals of Hematology · doi:10.1007/s00277-003-0773-3 · Cited by 62
Comparative Evolution of Morphological Regulatory Functions in Candida Species
Lackey, E., Vipulanandan, G., Childers, D. S., & Kadosh, D. (2013) · Eukaryotic Cell · doi:10.1128/ec.00164-13 · Cited by 61
Kilic, A., Li, H., Stratton, C. W., & Tang, Y.-W. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01546-06 · Cited by 61
Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs
Nett, J. E., & R. Andes, D. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0008-2014 · Cited by 60
St-Germain, G., Laverdière, M., Pelletier, R., René, P., Bourgault, A.-M., Lemieux, C., & Libman, M. (2008) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2008/634046 · Cited by 60
Rodríguez-Pardo, D., the Barcelona Candidemia Project Study Group, Almirante, B., Cuenca‐Estrella, M., Rodríguez-Tudela, J. L., Mensa, J., Ayats, J., Sánchez, F., & Pahissa, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03208.x · Cited by 60
Rosseti, I. B., Chagas, L. R., & Costa, M. S. (2013) · Lasers in Medical Science · doi:10.1007/s10103-013-1473-4 · Cited by 60
Eşel, D., Doğanay, M., Alp, E., & Sümerkan, B. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00714.x · Cited by 60
Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans
Hossain, M., Reyes, G. H., Long, L. A., Mukherjee, P. K., & Ghannoum, M. A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg230 · Cited by 60
Chen, A., & Sobel, J. D. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.1.21 · Cited by 59
Garbati, M. A., Alasmari, F. A., Al-Tannir, M. A., & Tleyjeh, I. M. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.10.004 · Cited by 59
Estradiol impairs the Th17 immune response against Candida albicans
Relloso, M., Aragoneses-Fenoll, L., Lasarte, S., Bourgeois, C., Romera, G., Kuchler, K., Corbí, A. L., Muñoz‐Fernández, M. Á., Nombela, C., Rodríguez‐Fernández, J. L., et al. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1110645 · Cited by 59
[Antibacterial drug resistance in Latin America: consequences for infectious disease control].
Casellas, J. M. (2011) · PubMed · Cited by 59
Transcriptional Circuits Regulating Developmental Processes in Candida albicans
Rodríguez, D. L., Quail, M. M., Hernday, A. D., & Nobile, C. J. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.605711 · Cited by 59
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi, V., Schizodimos, T., & Kotoulas, S. (2021) · Infection · doi:10.1007/s15010-021-01640-7 · Cited by 59
Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng, Y.-R., Lin, L., Young, T.-G., Liu, C.-E., Chen, C., & Tsay, R.-W. (2006) · PubMed · Cited by 59
Safdar, A., & Rolston, K. V. I. (2006) · Cancer · doi:10.1002/cncr.21801 · Cited by 59
Louie, L., Majury, A. L., Goodfellow, J., Louie, M., & Simor, A. E. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.11.4149-4151.2001 · Cited by 59
Vigilancia de resistencias a los antimicrobianos: estudio VIRA 2004
Picazo, J., Betriú, C., Rodríguez-Avial, I., Culebras, E., & Gómez, M. (2004) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(04)73153-5 · Cited by 59
Zaoutis, T. E., Foraker, E., McGowan, K. L., Mortensen, J. E., Campos, J. M., Walsh, T. J., & Klein, J. D. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.03.002 · Cited by 59
Mukherjee, P. K., Chandra, J., Kuhn, D. M., & Ghannoum, M. A. (2003) · Microbiology · doi:10.1099/mic.0.25829-0 · Cited by 59
Ren, D., Bedzyk, L. A., Setlow, P., England, D. F., Kjelleberg, S., Thomas, S. M., Ye, R. W., & Wood, T. K. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.8.4941-4949.2004 · Cited by 56
Predictors of Hospital-Acquired Urinary Tract–Related Bloodstream Infection
Greene, M. T., Chang, R., Kuhn, L. E., Rogers, M. A. M., Chenoweth, C. E., Shuman, E. K., & Saint, S. K. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/667731 · Cited by 58
Sheng, C., Xu, H., Wang, W., Cao, Y., Dong, G., Wang, S., Che, X., Ji, H., Miao, Z., & Yao, J. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.03.007 · Cited by 58
Central venous catheter (CVC) removal for patients of all ages with candidaemia
Janum, S., & Afshari, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011195.pub2 · Cited by 58
Biswas, S. K., & Chaffin, W. L. (2005) · Current Microbiology · doi:10.1007/s00284-005-4552-3 · Cited by 58
Fujihara, N., Saito, T., Kudo, T., Iinuma, Y., Ichiyama, S., & Takakura, S. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1128-2 · Cited by 58
Initial management of candidemia at an academic medical center: Evaluation of the IDSA guidelines
Patel, M., Kunz, D. F., Trivedi, V. M., Jones, M. G., Moser, S. A., & Baddley, J. W. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.12.010 · Cited by 58
Theiss, S., Kretschmar, M., Nichterlein, T., Hof, H., Agabian, N., Hacker, J., & Köhler, G. A. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02769.x · Cited by 55
Advances in Candida detection platforms for clinical and point-of-care applications
Safavieh, M., Coarsey, C., Esiobu, N., Memic, A., Vyas, J. M., Shafiee, H., & Asghar, W. (2017) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2016.1167667 · Cited by 57
“[25,26] Data from United States National Nosocomial Infection Surveillance (NNIS) system between 1990 and 1999 [27–30] showed that Candida was the fourth leading nosocomial pathogen.[31] Recent reports [32] identify Candida at the top of the pathogen list causing healthcare-associated bloodstream infections in the Uni…”
BackgroundRawajfah, O. A., Stetzer, F., & Hewitt, J. B. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/606167 · Cited by 57
Septic Shock Due to Candidemia: Outcomes and Predictors of Shock Development
Guzman (2011) · Journal of Clinical Medicine Research · doi:10.4021/jocmr536w · Cited by 47
Ghannoum, M. A., Chen, A. W., Buhari, M. A., Chandra, J., Mukherjee, P. K., Baxa, D. M., Golembieski, A., & Vázquez, J. A. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02660.x · Cited by 57
Conde-Rosa, A., Amador, R., Pérez-Torres, D., Colón, E., Sánchez-Rivera, C., Nieves-Plaza, M., González-Ramos, M., & Bertrán‐Pasarell, J. (2010) · PubMed · Cited by 57
A prospective epidemiological survey of candidaemia in Sweden
Klingspor, L., Törnqvist, E., Johansson, A., Petrini, B., Forsum, U., & Hedin, G. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310017447 · Cited by 46
Staphylococcus aureus Infections: New Challenges from an Old Pathogen
Kanafani, Z. A., & Fowler, V. G. (2006) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13086552 · Cited by 56
Antifungal activity and bioactive compounds produced by Bacillus mojavensis and Bacillus subtilis
Youcef-Ali, M., Chaouche, N. K., Dehimat, L., Insaf, B., Mounira, K. A., Hlne, C., & Thonart, P. (2014) · African Journal of Microbiology Research · doi:10.5897/ajmr2013.6327 · Cited by 56
Gwisai, T., Hollingsworth, N., Cowles, S. C., Tharmalingam, N., Mylonakis, E. E., Fuchs, B. B., & Shukla, A. (2017) · Biomedical Materials · doi:10.1088/1748-605x/aa7105 · Cited by 56
McDonald, L. C., Lauderdale, T.-L. Y., Shiau, Y., Chen, P., Lai, J., Wang, H., & Ho, M. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.09.021 · Cited by 56
Kempf, V. A. J., Mändle, T., Schumacher, U., Schäfer, A., & Autenrieth, I. B. (2005) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2004.12.006 · Cited by 56
Donabedian, S. M., Perri, M. B., Vager, D. L., Hershberger, E., Malani, P., Simjee, S., Chow, J. W., Vergis, E. N., Muder, R. R., Gay, K., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.02412-05 · Cited by 56
Gow, N. A. R., Knox, Y., Munro, C. A., & Thompson, W. D. (2003) · Medical Mycology · doi:10.1080/13693780310001600859 · Cited by 56
Regulation of sugar transport and metabolism by the Candida albicans Rgt1 transcriptional repressor
Sexton, J. A., Brown, V., & Johnston, M. (2007) · Yeast · doi:10.1002/yea.1514 · Cited by 55
Length of stay and charges associated with health care-acquired bloodstream infections
Rawajfah, O. A., Hewitt, J. B., Stetzer, F., & Cheema, J. (2011) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.03.014 · Cited by 55
Mortality in patients with early- or late-onset candidaemia
Rosa, F. G. D., Trecarichi, E. M., Montrucchio, C., Losito, A. R., Raviolo, S., Posteraro, B., Corcione, S., Giambenedetto, S. D., Fossati, L., Sanguinetti, M., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks480 · Cited by 55
Kamana, M., Escalante, C. P., Mullen, C. A., Frisbee‐Hume, S. E., & Rolston, K. V. I. (2005) · Cancer · doi:10.1002/cncr.21144 · Cited by 55
In vitro synergy of baicalein and gentamicin against vancomycin-resistant Enterococcus.
Chang, P. C., Li, H. Y., Tang, H. J., Liu, J. W., Wang, J. J., & Chuang, Y. C. (2007) · PubMed · Cited by 55
Pooled analysis of T2 Candida for rapid diagnosis of candidiasis
Tang, D., Chen, X., Zhu, C.-G., Li, Z., Xia, Y., & Guo, X. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4419-z · Cited by 54
Barker, K. S., Liu, T., & Rogers, P. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/432487 · Cited by 47
Use of chromogenic medium in the isolation of yeasts from clinical specimens
Murray, C. K., Beckius, M. L., Green, J. A., & Hospenthal, D. R. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45942-0 · Cited by 54
Pathogenesis I: interactions of host cells and fungi
Clemons, K. V., Calich, V. L. G., Burger, E., Filler, S. G., Graziuttit, M., Murphy, J., Roilides, E., Campa, A., Dias, M. R., Jr, J. E. E., et al. (2000) · Medical Mycology · doi:10.1080/mmy.38.s1.99.111 · Cited by 54
Janssen, P. A., & van den Bossche, H. (1982) · PubMed · Cited by 54
Fang, C.-T., Shau, W.-Y., Hsueh, P.-R., Chen, Y.-C., Wang, J.-T., Hung, C.-C., Huang, L. Y. L., & Chang, S.-C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl006 · Cited by 53
Silva, V., Díaz, M. C., & Febré, N. (2004) · Medical Mycology · doi:10.1080/13693780410001657153 · Cited by 53
Stam, W. B., O’Sullivan, A. K., Rijnders, B. J. A., Lugtenburg, E. J., Span, L. F. R., Janssen, J. J. W. M., & Jansen, J. P. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01141.x · Cited by 53
Chang, H., Tsai, P.-W., Huang, H.-H., Liu, Y.-S., Chien, T.-S., & Lan, C. (2011) · Biochemical Journal · doi:10.1042/bj20111454 · Cited by 53
Swinne, D., Watelle, M., Van der Flaes, M., & Nolard, N. (2004) · Mycoses · doi:10.1111/j.1439-0507.2004.00971.x · Cited by 52
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients
Playford, E. G., Webster, A. C., Sorrell, T. C., & Craig, J. C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004920.pub2 · Cited by 52
Reitzel, R. A., Dvorak, T. L., Hachem, R. Y., Fang, X., Jiang, Y., & RAAD, I. I. (2009) · American Journal of Infection Control · doi:10.1016/j.ajic.2008.07.003 · Cited by 52
Pérez, A., Ramage, G., Blanes, R., Murgui, A., Casanova, M., & Martínez, J. P. (2011) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00714.x · Cited by 43
Candida albicans: Molecular interactions with Pseudomonas aeruginosa and Staphylococcus aureus
Lindsay, A. K., & Hogan, D. A. (2014) · Fungal Biology Reviews · doi:10.1016/j.fbr.2014.10.002 · Cited by 52
Severe sepsis—National estimates
Wenzel, R. P., & Edmond, M. B. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00028 · Cited by 50
Self-citationPassos, X. S., Costa, C. R., de Araújo, C. R., Nascimento, E. S., Souza, L. K. H. E., Fernandes, O. D. F. L., Sales, W. S., & Silva, M. D. R. R. (2007) · Mycopathologia · doi:10.1007/s11046-007-0094-5 · Cited by 52
Luchi, M., & Morrison, D. C. (2000) · Infection and Immunity · doi:10.1128/iai.68.4.1899-1904.2000 · Cited by 45
Joseph, N. M., Bhanupriya, B., Shewade, D. G., & Harish, B. N. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/11029.5537 · Cited by 52
Emerging Therapies for Serious Gram-Positive Bacterial Infections: A Focus on Linezolid
Plouffe, J. F. (2000) · Clinical Infectious Diseases · doi:10.1086/314080 · Cited by 52
Lee, J.-S., Shin, J. H., Lee, K., Kim, M.-N., Shin, B.-M., Uh, Y., Lee, W.-G., Lee, H. S., Chang, C. L., Kim, S. H., et al. (2007) · Yonsei Medical Journal · doi:10.3349/ymj.2007.48.5.779 · Cited by 51
Pais, P., Galocha, M., Viana, R., Cavalheiro, M., Pereira, D., & Teixeira, M. C. (2019) · Microbial Cell · doi:10.15698/mic2019.03.670 · Cited by 51
Thakral, F., Bhatia, G. K., Tuli, H. S., Sharma, A. K., & Sood, S. (2021) · Current Pharmacology Reports · doi:10.1007/s40495-021-00248-7 · Cited by 51
Greiner, W., Rasch, A., Köhler, D., Salzberger, B., Fätkenheuer, G., & Leidig, M. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01622.x · Cited by 51
Baddley, J. W., & Moser, S. A. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.05.003 · Cited by 51
Clinical characteristics and risk factors of ocular candidiasis
Nagao, M., Saito, T., Doi, S., Hotta, G., Yamamoto, M., Matsumura, Y., Matsushima, A., Ito, Y., Takakura, S., & Ichiyama, S. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.03.006 · Cited by 51
Bourgogne, A., Thomson, L. C., & Murray, B. E. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-17 · Cited by 51
Amran, F. B., Aziz, M. N., Ibrahim, H. M., Atiqah, N. H., Parameswari, S., Hafiza, M. R., & Ifwat, M. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.027631-0 · Cited by 51
Safdar, A., Chaturvedi, V., Koll, B. S., Larone, D. H., Perlin, D. S., & Armstrong, D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3268-3272.2002 · Cited by 46
Epidemiology of bacteriuria caused by vancomycin-resistant enterococci—a retrospective study
Wong, A. H. M., Wenzel, R. P., & Edmond, M. B. (2000) · American Journal of Infection Control · doi:10.1067/mic.2000.106904 · Cited by 51
Self-citationInitial results from a longitudinal international surveillance programme for anidulafungin (2003)
Messer, S. A., Kirby, J. T., Sader, H. S., Fritsche, T. R., & Jones, R. N. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh504 · Cited by 52
Self-citationGeorge, B. J., Horvath, L. L., & Hospenthal, D. R. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.1.433-435.2005 · Cited by 50
Metadata
- Authors
- Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Wenzel, Richard P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08
- Volume
- 29
- Issue
- 2
- Pages
- 239-244
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2157766752
- Cited by
- 1,387
- References
- 16
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 13 · 2023: 13 · 2022: 18 · 2021: 21 · 2020: 23 · 2019: 37 · 2018: 31 · 2017: 36 · 2016: 41 · 2015: 33 · 2014: 56 · 2013: 55 · 2012: 55
- FWCI
- 47.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- nosocomial bloodstream infection, hospital-acquired bacteremia, coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus, Gram-positive bacteria, Gram-negative bacteria, fungemia, methicillin resistance, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, Streptococcus viridans, neutropenia, intensive care unit, empirical antibiotic therapy, infection surveillance
- MeSH terms
- Candida, Cross Infection, Gram-Negative Bacteria, Gram-Positive Bacteria, Hospitals, Humans, Neutropenia, Staphylococcus, United States, Fungemia, Bacteremia, Enterococcus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.